We are seeking securities analysts and investment professionals who will read and review the book.
IBM: Nobody Looked makes a specific, evidence-based claim: that IBM's financial decline was documented in its own SEC filings for over two decades, and that every professional in the chain of responsibility — sell-side analysts, buy-side advisors, board members, auditors, and regulators — either failed to see it or failed to act on it.
The book names names. It cites filings. It shows the math. And it arrives at a conclusion that the securities industry will find uncomfortable: the numbers were always there, and nobody looked.
We believe the strongest test of any argument is to invite its critics to examine it. That is why we are extending this invitation to working securities analysts, portfolio managers, research directors, and other investment professionals.
We are offering advance access to the complete manuscript of IBM: Nobody Looked to qualified securities analysts and investment professionals who are willing to:
This is not a request for endorsement. It is a request for engagement. If the analysis is flawed, we want to know. If the conclusions are wrong, show us where. And if the numbers are right — if the data says what we say it says — then say so, and let the record reflect it.
The investment industry operates on a foundation of trust. Investors trust their advisors. Advisors trust the analysts. Analysts trust the filings. But when the filings tell one story and the recommendations tell another, the question is not whether someone made a mistake. The question is whether the system itself is designed to prevent anyone from being required to notice.
IBM: Nobody Looked argues that this is exactly what happened — not through conspiracy, but through a structure of incentives, conventions, and professional norms that made it possible for an iconic American company to decline in plain sight while every professional whose job it was to protect investors continued to say "buy."
If that argument is wrong, the industry should be eager to demonstrate it. If it is right, the industry should be the first to acknowledge it.
To request a review copy of the manuscript, please contact the author directly. Include your name, title, firm, and a brief note about your interest in reviewing the book.